BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

The company unveiled plans last week to test its GLP-1/glucagon dual receptor agonist in alcohol use disorder and ...

Your body naturally produces the hormones GLP-1 and gastric inhibitory polypeptide receptor (GIP), known as incretin hormones. These hormones have several functions: In people with type 2 diabetes ...

In contrast, none of the DPP-4 inhibitors lowers blood glucose or stimulates insulin secretion in mice with genetic disruption of both the GIP and GLP-1 receptors (dual incretin receptor knockout ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...